However, the clinical presentation and courses of previously reported patients with WIP deficiency were more heterogeneous than those of WAS patients (6–8), especially with regards to very early onset of severe, life-threatening immunodeficiency. The gene discussed is WIPF1; the disease is Wiskott-Aldrich syndrome.